CIK 0001023024
- Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 582301143
- Phone
- +1 609-759-1810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- 4 Shares withheld for taxes SVP, GENERICS gave up 2,342 shares (to pay taxes)
- 4 Shares withheld for taxes SVP AND CFO gave up 3,503 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT & CEO gave up 13,662 shares (to pay taxes)
- 4 Shares withheld for taxes SVP OPS & PROD DEV gave up 2,460 shares (to pay taxes)
- 4 Shares withheld for taxes HEAD OF RARE DISEASE gave up 1,292 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, GENERICS gave up 1,275 shares (to pay taxes)
- 4 Open-market sale 10% owner sold 200,000 shares at $38.50 ($7,700,000)
- 4 Grant or award SVP, CHIEF HR OFFICER acquired 16,433 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes PRESIDENT & CEO gave up 3,646 shares (to pay taxes)
- 4 Open-market sale SVP OPS & PROD DEV sold 18,066 shares at an average $37.26 ($673,069)
- 4 Grant or award SR. VP, GENERAL COUNSEL & SEC. acquired 19,280 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award SVP, GENERICS acquired 6,476 shares (grant or award)
- 4 Grant or award HEAD OF RARE DISEASE acquired 6,476 shares (grant or award)
- 4 Grant or award SVP OPS & PROD DEV acquired 6,644 shares (grant or award)
- 4 Grant or award SENIOR VICE PRESIDENT AND CFO acquired 11,291 shares (grant or award)
- 4 Grant or award PRESIDENT & CEO acquired 33,352 shares (grant or award)
- 4 Grant or award Director acquired 10,049 shares (grant or award)
- 4 Grant or award Director acquired 10,049 shares (grant or award)
Page 15 of 42 · 835 filings